Optimization of long term control of oral anticoagulation by patient self-management;Verbesserung der langzeitkontrolle der oralen antikoagulation durch patienten-selbstmanagement

Herz Kreislauf

Volumn 31, Issue 10, 1999, Pages 393-397

  Mengden, Th ^a   Heidgen, F J ^a   Vetter, H ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Bleeding; Oral anticoagulant therapy; Self management; Thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; COUMARIN; PHENPROCOUMON; PROTHROMBIN; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; COST CONTROL; HUMAN; INTERNATIONAL STANDARD UNIT; LONG TERM CARE; MEDICAL CARE; ORAL DRUG ADMINISTRATION; PROTHROMBIN TIME; QUALITY OF LIFE; REVIEW; SELF CARE; THROMBOEMBOLISM;

EID: 0032871196     PISSN: 00467324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Anderson DR,Harrison L, Hirsh J. Evaluation of portable prothrombin time monitors for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med1993; 153: 1441-7.
2. Ansell J. The value of a specialized program for the management of oral anticoagulation. Hämostaesologie 1997; 17: 133-6.
3. Ansell JE,Holden A, Knopic N. Patient self-management of oral anticoagulation guided by capillary whole blood prothrombin time. Arch Intern Med1989; 149:2509-11.
4. Bernardo A,Taborski U, Wittstamm FJ, eds. Arbeitsgemeinschaft Selbstkontrolle der Antikoagulation: Standards und Informationen. Bad Nauheim: Eigenverlag1996: 4. Auflage.
5. Bernardo A. Optimierung der Langzeit-Antikoagulation durch Patienten-Selbstmanagement? Z Kardiol 1998:87: 75-81.
6. Cortelazzo S,Finazzi G, Viero P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prostheses attending an anticoagulation clinic. Thromb Haemost1993; 69 316-20.
7. 7EPSIM Research Group. A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Eng/ J Med 1982:307- 701-8.
8. Friedli B,Aerichide N, Grondin P, Campeau L. Thromboembolic complications of heart valve prostheses. Am Heart J1971; 81: 702-8.
9. Gitter MJ,Jaeger TM, Peterson TM, Gersh BJ, Silverstein MD. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochestet, Minnesota. Mayo Clin Proc1995; 70. 725-33.
10. Horstkotte D,Piper C, Wiemer M, Schulte HD, Schultheiß HP. Improvement of prognosis by home prothrombin estimation in patients with life long anticoagulation therapy Eur Heart J1996; 17 (SupplJ. 230.
11. Horstkotte D,Piper C, Wiemer M, Schultheiß HP. Optimization of oral anticoagulation, solved and unsolved problems with mechanical heart valve prostheses. In. Knan A, Matloff JM, Nicoloff DM, eds. Advancing the technology ofbileaflet mechanical heart valves. Darmstadt: SteinkopH Verlag I998: 1-9.
12. Jorgensen T. Anticoagulant therapy in community care - a technology assessment. Copenhagen: Danish Hospital Institute, October1991.
13. Körfer R,Körtke H. ESCAT - Early Self Controlled Ant/coagulation Trial. In: Khan A, Mat/off JM, Nicoloff DM, eds. Advancing the technology ofbileaflet mechanical heart valves. Darmstadt: Stemkopff Verlag1998.
14. Loeliger A. Was kann von Langzeitantikoagulation bei kardialer und arterieller Thrombose heute erwartet werden? Schweiz Med Wschr 1985: 115: 1483-94.
15. Mengden T,Kraft K, Vetter H. Verbesserung der Langzeitkontrolle der arteriellen Hypertonie mit B/utdruckselbstmessung. Deutsches Ärzteblatt1998;95:A-2833-42.
16. Sawicki PT,Mühlhauser l, Didjurgeit U, Baumgartner A, Bender R, Berger M. Intensified antihypertensive therapy is associated with improved survival in type1 diabetic patients with nephropathy. J Hypertens 1995: 13:933-8
17. Müller-Beißenhirtz W,Deickert F, Lang H, Schöndorf T, Spanuth E, Taborski U, Witt I. Selbstkontrolle der oralen Antikoagulation. Standortbestimmung, j Lab Med1997:21: 558-62.
18. Saour JN,Sieck JO, Mamo LA, Callus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med1990: 322: 428-32.
19. Sawicki PT,for the Working Group for the Study of Patient Self-Management of Oral Anticoagulation. A structured teaching and self-management program for patients receiving oral anticogulation A randomized controlled trial. J Am Med Ass1999: 281: 145-50.
20. Schachner A. Deviri E,Shabat S. Patient-regulated anticoagulation in thrombosis, embolism and bleeding. London: ICR Publishers1992: 318-24.
21. van den Besselaar AMPH,Breddin K, Lutze G, Parker-Williams J, Taborski U, Vogel G, Tritschler W, Zerback R, Leinberger R. Multicenter evaluation of a new capillary prothrombin time monitoring system. Blood Coagul Fibrmolysis1995: 6: 726-32.
22. White RH,McCurdy SA, v. Marrensdorf H, Woodruff D, Leftgott L. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. Ann Intern Med1989: 111: 730-7.
23. Wittstamm FJ,Benesch L Sicheres QuickwertManagement durch Selbstbestimmung. Z Kardiol1992:81: 176-9.